Skip to main content
JPGN Reports logoLink to JPGN Reports
. 2026 Apr 7;7(3):398–402. doi: 10.1002/jpr3.70172

Hodgkin lymphoma of the ampulla of Vater: A rare cause of obstructive jaundice in children

Sultana Alshammari 1, Homoud Alhebbi 1,✉, Awad Al Qahtani 1,2, Sarah Algubaisi 1, Faisal Alhaffaf 1, Abdulrahman Al Robayan 3, Mohammed Almutairi 4, Saeed Alshieban 5,6,7,8, Mohammad Alshahrani 9, Tarek Khaled Alfawzan 10, Khalid Alkhamis 10, Ibrahim Al Hasan 11, Sami Wali 1
PMCID: PMC13398917  PMID: 42499748

Abstract

Hodgkin lymphoma (HL) has a wide spectrum of presentation. Most cases affect lymph nodes (nodal), while extranodal involvement is rare. Whereas the gastrointestinal tract is enriched with lymphoid tissues, the ampulla of Vater is not rich in lymphoid tissue. Involvement of the ampulla of Vater with HL has rarely been reported in adults and has never been reported in children. Its presentation mimics other causes of obstructive jaundice, and immunodeficiency increases the risk of lymphoma. There have been reports of cutaneous T‐cell lymphomas and one case of HL following the use of dupilumab, a biological agent that has been used to treat atopic dermatitis. Here, we report a case of HL of the ampulla of Vater in a patient with hyper‐IgE syndrome type 2 and severe atopic dermatitis.

Keywords: dupilumab, gastrointestinal tract, hyper‐IgE syndrome type 2, lymph nodes, severe atopic dermatitis


What is Known

  • •

    Extra nodal gastrointestinal (GI) lymphoma is rare in children, and it is mainly non‐Hodgkin lymphoma.

  • •

    There are a few reported cases linking dupilumab with skin lymphoma.

What is New

  • •

    Hodgkin lymphoma of the ampulla of Vater is rare in children.

  • •

    Immunodeficiency might increase the risk of lymphoma in patients receiving dupilumab and careful monitoring is important for early detection.

1. INTRODUCTION

Hodgkin lymphoma (HL) is a hematologic malignancy characterized by the presence of Reed‐Sternberg cells, which originate from B lymphocytes and are typically found in lymphoid tissues. 1 While HL predominantly affects lymph nodes, its occurrence in extranodal sites is rare and poses distinct diagnostic and treatment challenges. The presentation of extranodal HL in the gastrointestinal (GI) tract is atypical, and symptoms may overlap with those of more common GI conditions, such as malignancies or inflammatory diseases, making accurate diagnosis challenging. One such rare extranodal site is the ampulla of Vater, located in the duodenum, where the common bile duct and pancreatic duct converge. Although few cases of HL affecting the ampulla of Vater have been reported in adults, not a single case has been reported in children. 2 We report the case of a child who presented with HL of the ampulla of Vater following a 9‐month dermatitis course to treat severe atopic dermatitis (AD).

2. CASE REPORT

An 11‐year‐old girl presented with a 14‐day history of jaundice. This was preceded by intermittent fever, reaching up to 39°C for 1 month. She had severe AD, diagnosed at the age of six, that was managed with dupilumab for 9 months prior to this presentation. There were no symptoms of facial rash, oral ulcers, changes in stool color, melena, vomiting, hematemesis, joint pain, neuropsychiatric manifestations, appetite loss, weight loss, or night sweats. She is the first child of consanguineous parents, with two healthy siblings and no family history of liver disease or malignancy.

2.1. Clinical findings and diagnostic workup

On physical examination, the patient was febrile and jaundiced. There was no lymphadenopathy, clubbing, or hepatosplenomegaly. Laboratory investigations revealed white blood cells 17,000/μL (4000–11,000/μL), eosinophils 780/μL (0–200/μL), hemoglobin 11.1 g/dL (12–16 g/dL), platelets 414,000/μL (150,000–400,000/μL), immunoglobulin E (IgE) 1389 kU/L (0–100) total bilirubin 92 μmol/L (5–21 μmol/L), conjugated bilirubin 86 μmol/L (0–6 μmol/L), alkaline phosphatase 648 U/L (129–417 U/L), gamma‐glutamyl transferase (GGT) 151 U/L (5–36 U/L) and cancer antigen 19‐9 (CA 19‐9) 7556 kU/L (0–34 kU/L). Workup for infectious causes of hepatitis was negative. Ultrasound and CT scan of the abdomen showed severe intrahepatic and extrahepatic bile duct dilation and mural thickening of the common bile duct, extending to the ampullary region. Magnetic resonance cholangiopancreatography (MRCP) showed diffuse biliary ductal dilatation; Right and left hepatic ducts measure 1.0 and 1.5 cm in diameter, respectively. The common bile duct measures 2.0 cm in diameter. There was an ampullary intraductal mass with mild peripheral enhancement of the mass (Figure 1). Endoscopic retrograde cholangiopancreatography (ERCP) using Olympus JF 260 scope identified large periampullary ulcers extending to the papilla with narrowing of the distal common bile duct (Figure 2). A biliary stent (Meical cook; Fr 10 × 9 cm) was inserted for drainage. Figure 3 shows the histopathological examination of the biopsies obtained from the ulcerative lesion showed the presence of Reed‐Sternberg cells, and immunohistochemical analysis was positive for CD30, CD15, and EBV‐EBER, which proves the diagnosis of HL. A PET‐CT scan showed localized hypermetabolic activity at the ampulla without evidence of distant metastasis, confirming the disease stage.

Figure 1.

Figure 1

(A) Coronal T2‐weighted image showing diffuse biliary ductal dilatation. (B) Axial T2 weighted image showing ampullary intraductal mass with intermediate signal intensity. (C) Magnetic resonance cholangiopancreatography (MRCP) showing abrupt narrowing at the level of the distal common bile duct (CBD). (D) Delayed phase postcontrast T1‐weighted image showing mild peripheral enhancement of the mass.

Figure 2.

Figure 2

(A) Endoscopic picture showing canulation of the ulcerating ampulla of Vater by a catheter during endoscopic retrograde cholangiopancreatography (ERCP). (B) ERCP picture showing distal narrowing of the common bile duct (CBD) with proximal dilatation of the CBD.

Figure 3.

Figure 3

Histopathological morphology findings. (A) Duodenal mucosa showing ulceration and granulation tissue (H&E stain, 40X). (B, C) The atypical cells show large, irregular nuclei, coarse chromatin, prominent nucleoli, and abundant cytoplasm. The background shows a mix of small lymphoid cells, eosinophils, and histiocytes (H&E stain, 100X and 400X). The tumor large cells are positive for (D) CD30 (E), CD15 (F), and Epstein‐Barr Virus ‐ Encoded RNA (EBV‐EBER).

2.2. Treatment

The patient was started on a chemotherapy regimen, consisting of Adriamycin, bleomycin, vinblastine, and decarbonize. Considering the patient's chronic history of itching, further genetic testing revealed a mutation in the AR DOCK8 gene, indicating hyper‐IgE syndrome type 2.

2.3. Outcome and follow‐up

The patient is currently undergoing regular follow‐up to monitor her response to chemotherapy and the progression of her condition. Three further endoscopic biopsies after 4, 7, and 9 months from the original biopsy did not show any signs of HL. The stent was removed after 7 months from insertion. She is stable after 18 months from diagnosis. Due to her genetic diagnosis, a human leukocyte antigen (HLA) typing was conducted among family members in preparation for a potential bone marrow transplant, which is considered the definitive treatment for hyper‐IgE syndrome. The patient's clinical status remains stable, and she continues to be evaluated for any recurrence or complications associated with her treatment.

3. DISCUSSION

Extranodal presentation of HL is rare and accounts for 1%–4% of all HL cases, whereas non‐Hodgkin lymphoma (NHL) is more frequently observed in this region. Symptoms of extra nodal HL may overlap with those of more common GI conditions, such as malignancies or inflammatory diseases, making accurate diagnosis challenging. 3 , 4 Involvement of the ampulla of Vater with HL is rare, with few cases reported in adults but none in children. One case of Burkitt lymphoma was reported to affect the biliary tract in children. 5 The rarity of HL in the ampulla of Vater is attributed to the limited lymphoid tissue present in this region compared to other parts of the GIT. Presentation mimics any other cause of obstructive jaundice and could have challenges in diagnosis due to an obscure presentation. 6

Hyper‐IgE syndrome is a rare immunodeficiency disorder characterized by elevated levels of IgE and recurrent infections, and it is known to predispose patients to malignancies, particularly lymphomas. Although NHL is more commonly associated with hyper‐IgE syndrome, this case illustrates that HL can also occur in the context of this genetic disorder. The involvement of the ampulla of Vater in this context is particularly noteworthy, as it highlights the need for clinicians to consider both genetic and environmental factors when diagnosing rare malignancies in patients with immunodeficiencies. 7 , 8

Dupilumab is a humanized IgG4 monoclonal antibody that targets the interleukin (IL)‐4 receptor alpha chain in the heterodimeric IL‐4 receptor complex, blocking the signaling of IL‐4 and IL‐13, type 2 cytokines known to play a key role in the pathogenesis of allergic disorders such as AD, asthma, eosinophilic esophagitis, and food allergies. Twenty‐seven cases of cutaneous T‐cell lymphomas have been reported following the use of dupilumab for AD. One case of HL was reported after using dupilumab for AD. 9 , 10 We report the first pediatric case of HL involving the ampulla of Vater. The presentation was similar to any obstructive jaundice. It was successfully treated with standard treatment for HL. It is difficult to prove that using dupilumab is the cause of HL, as contradicting information suggests that dupilumab might improve the outcome of HL by inhibiting ATAT6 activation. 11 Hyper‐IgE syndrome is known to increase the risk of lymphoma. Dupilumab may play a role in the development of HL in our case. 9 , 10

4. CONCLUSION

HL of the ampulla of Vater is rare in children. It is responsive to chemotherapy if discovered early. Immunodeficiency and hyper‐IgE syndrome increase the risk of non‐HL lymphoma development and rarely HL. The link between dupilumab and the development of HL needs further longitudinal study. In the meantime, it is seemingly better to use it cautiously in any patient with immunodeficiency, careful monitoring of skin changes, and probably abdominal imaging using ultrasound during the treatment.

CONFLICT OF INTEREST STATEMENT

The authors declare no conflicts of interest.

ETHICS STATEMENT

This study was approved by the Institutional Review Board (IRB) of the Prince Sultan Military Medical City, Scientific Research Center in Riyadh, Saudi Arabia (IRB Approval No: E‐2464). Informed written consent was obtained from the child's parent(s) after thorough explanation of the study's purpose and procedures.

ACKNOWLEDGMENTS

The authors have no funding to report.

DATA AVAILABILITY STATEMENT

Data available on request.

REFERENCES

  • 1. Aggarwal P, Limaiem F. Reed Sternberg Cells. StatPearls. StatPearls Publishing; 2024. [PubMed] [Google Scholar]
  • 2. Schreeg ME, Cullen JM, Robertson J, Gookin JL. Histologic characterization of the major duodenal papilla and association with concurrent biliary, pancreatic, and intestinal pathology in cats. Vet Pathol. 2024;61(2):207‐220. 10.1177/03009858231189450 [DOI] [PubMed] [Google Scholar]
  • 3. Takahara T, Satou A, Tsuzuki T, Nakamura S. Hodgkin lymphoma: biology and differential diagnostic problem. Diagnostics. 2022;12(6):1507. 10.3390/diagnostics12061507 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Dumonceau JM, Delhaye M, Charette N, Farina A. Challenging biliary strictures: pathophysiological features, differential diagnosis, diagnostic algorithms, and new clinically relevant biomarkers ‐ part 1. Therap Adv Gastroenterol. 2020;13:1756284820927292. 10.1177/1756284820927292 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Pawar VB, Surude R, Sonthalia N, Jain S, Contractor Q, Rathi P. An unusual case of obstructive jaundice: ampullary Burkitt lymphoma. J Gastrointest Oncol. 2019;10(2):379‐383. 10.21037/jgo.2018.07.13 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Shirwaikar Thomas A, Schwartz M, Quigley E. Gastrointestinal lymphoma: the new mimic. BMJ Open Gastroenterol. 2019;6(1):e000320. 10.1136/bmjgast-2019-000320 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Al‐Shaikhly T, Ochs HD. Hyper IgE syndromes: clinical and molecular characteristics. Immunol Cell Biol. 2019;97(4):368‐379. 10.1111/imcb.12209 [DOI] [PubMed] [Google Scholar]
  • 8. Herber M, Mertz P, Dieudonné Y, et al. Primary immunodeficiencies and lymphoma: a systematic review of literature. Leuk Lymphoma. 2020;61(2):274‐284. 10.1080/10428194.2019.1672056 [DOI] [PubMed] [Google Scholar]
  • 9. Park A, Wong L, Lang A, Kraus C, Anderson N, Elsensohn A. Cutaneous T‐cell lymphoma following dupilumab use: a systematic review. Int J Dermatol. 2023;62(7):862‐876. 10.1111/ijd.16388 [DOI] [PubMed] [Google Scholar]
  • 10. Nakazaki K, Yoshida M, Masamoto Y, et al. Discordant lymphomas of classic Hodgkin lymphoma and peripheral T‐cell lymphoma following dupilumab treatment for atopic dermatitis. Int J Hematol. 2022;116(3):446‐452. 10.1007/s12185-022-03330-y [DOI] [PubMed] [Google Scholar]
  • 11. Uchida H, Kamata M, Nagata M, et al. Development of diffuse large B‐cell lymphoma during dupilumab treatment in a patient with atopic dermatitis: a case report. J Cutaneous Immunol Allerg. 2021;4:143‐145. 10.1002/cia2.12178 [DOI] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Data available on request.


Articles from JPGN Reports are provided here courtesy of Wiley

RESOURCES